Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxil + Benzodiazepines in Depression
NCT00259883Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of paroxetine in major depressive disorder (MDD), sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00259883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259883.